Combination Chemotherapy of Advanced Non Hodgkin Lymphoma with Bleomycin , Adriamycin , Cyclophosphamide , Vincristine , and Prednisone ( BACOP

Seventy-three patients with advanced non-Hodgkin lymphoma were treated with bleomycin, Adriamycin, cyclophosphamide, vincristine (Oncovin) and prednisone (BACOP), administered intensively during a 7-wk induction course followed by intermittent cycles every 3 wk for a total of 28 wk. The objective response in 44 evaluable nonleukemic patients with diffuse histology was 86%, with 66% achieving a complete remission (CR), varying from 80% for diffuse poorly differentiated lymphocytic (DPDL) to 56% for diffuse histiocytic (DH) lymphoma. In patients with nodular histology 89% (8/9) achieved a CR with a projected 75% of patients in CR at 14 me. Median follow-up from time of CR

[1]  B. Telek,et al.  [Involvement of the central nervous system in non-Hodgkin's lymphoma]. , 1986, Orvosi hetilap.

[2]  C. Alvarado,et al.  Acute lymphocytic leukemia in childhood. , 1982, Journal of the Medical Association of Georgia.

[3]  A. Freeman,et al.  Treatment of acute lymphocytic leukemia by high-dose intravenous methotrexate. , 1976, Cancer research.

[4]  J. Tobias,et al.  Prophylactic granulocyte support in experimental septicemia. , 1976, Blood.

[5]  G. Johnston,et al.  67Ga accumulation in pulmonary lesions associated with bleomycin toxicity , 1975, Cancer.

[6]  E. Henderson,et al.  Filtration leukapheresis for granulocyte transfusion therapy. Clinical and laboratory studies. , 1975, The New England journal of medicine.

[7]  J. Bertino,et al.  Long‐term remission in diffuse histiocytic lymphoma treated with combination sequential chemotherapy , 1975, Cancer.

[8]  D. Rosenthal,et al.  Advanced lymphosarcoma treated by total body irradiation. , 1975, The British journal of cancer. Supplement.

[9]  V. Devita,et al.  Therapy of advanced lymphocytic lymphoma a preliminary report of a randomized trial between combination chemotherapy (CVP) and intensive radiotherapy. , 1975, The British journal of cancer. Supplement.

[10]  V. Devita,et al.  ADVANCED DIFFUSE HISTIOCYTIC LYMPHOMA, A POTENTIALLY CURABLE DISEASE RESULTS WITH COMBINATION CHEMOTHERAPY , 1975, The Lancet.

[11]  T. A. Connors,et al.  Combination Chemotherapy , 1974, Proceedings of the Royal Society of Medicine.

[12]  V. Devita,et al.  Potential for prolonged disease-free survival following combination chemotherapy of non-Hodgkin's lymphoma. , 1974, Blood.

[13]  S K Carter,et al.  Adriamycin. A new anticancer drug with significant clinical activity. , 1974, Annals of internal medicine.

[14]  D. Rosenthal,et al.  Neurological complications of acute leukemia in adults: changing rate. , 1973, Annals of internal medicine.

[15]  Z. Fuks,et al.  Non‐hodgkin's lymphomas iv. clinicopathologic correlation in 405 cases , 1973, Cancer.

[16]  S. Jones,et al.  Non‐Hodgkin's lymphomas. II. Single agent chemotherapy , 1972, Cancer.